CytomX Therapeutics CTMX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's total current assets?
- CytomX Therapeutics (CTMX) reported total current assets of $353.1M in Q1 2026.
- How has CytomX Therapeutics's total current assets changed year-over-year?
- CytomX Therapeutics's total current assets increased by 307.6% year-over-year, from $86.63M to $353.1M.
- What is the long-term trend for CytomX Therapeutics's total current assets?
- Over 5 years (2020 to 2025), CytomX Therapeutics's total current assets has grown at a -15.0% compound annual growth rate (CAGR), from $324.01M to $143.92M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.